A six-month competition organized by NeuroAge Therapeutics and Longevity Global will track roughly 500 participants across methylation clocks, organ-specific ages, cognitive and facial age estimates, and functional markers such as VO2 max and grip strength. The intent is to assemble a multi-omic, imaging-linked dataset that does not currently exist and to test whether aging clocks can serve as short-term surrogate endpoints. An analysis of 51 interventions found that age reversal is more achievable in people who begin in poorer health, prompting separate awards for greatest improvement and lowest final age.
Key Points
- 500 participants measured across brain, body, face and function
- Age reversal comes more easily to those starting unhealthy
- Brain volume responds to balance training, HIIT, cognitive challenge
Longevity Analysis
Single-number biological age estimates tell you direction without location; organ-specific clocks paired with imaging and functional testing identify which systems are actually drifting and which interventions move them. Glorioso's own case — normal cholesterol management guidance overturned by white matter hyperintensities and a calcium score of 10 — illustrates how composite measurement corrects misread signals that standard screening leaves untouched. The harder question the project addresses is validation: whether epigenetic and proteomic markers can substitute for decades of outcome data, the way amyloid markers now function in Alzheimer's trials, and whether sustained lifestyle execution over six months produces changes large enough to register across circulation, cognition, muscular capacity and regenerative tissue measures.
Original published by Longevity.Technology, by Kyle Umipig.